Your browser doesn't support javascript.
loading
New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections
Chumbita, Mariana; Monzo-Gallo, Patricia; Lopera-Mármol, Carlos; Aiello, Tommaso Francesco; Puerta-Alcalde, Pedro; Garcia-Vidal, Carolina.
Afiliación
  • Chumbita, Mariana; University of Barcelona. Hospital Clinic of Barcelona-IDIBAPS. Department of Infectious Diseases. Barcelona. Spain
  • Monzo-Gallo, Patricia; University of Barcelona. Hospital Clinic of Barcelona-IDIBAPS. Department of Infectious Diseases. Barcelona. Spain
  • Lopera-Mármol, Carlos; University of Barcelona. Hospital Clinic of Barcelona-IDIBAPS. Department of Infectious Diseases. Barcelona. Spain
  • Aiello, Tommaso Francesco; University of Barcelona. Hospital Clinic of Barcelona-IDIBAPS. Department of Infectious Diseases. Barcelona. Spain
  • Puerta-Alcalde, Pedro; University of Barcelona. Hospital Clinic of Barcelona-IDIBAPS. Department of Infectious Diseases. Barcelona. Spain
  • Garcia-Vidal, Carolina; University of Barcelona. Hospital Clinic of Barcelona-IDIBAPS. Department of Infectious Diseases. Barcelona. Spain
Rev. esp. quimioter ; Rev. esp. quimioter;35(Supl. 3): 51-53, Oct. 2022.
Article en En | IBECS | ID: ibc-210749
Biblioteca responsable: ES1.1
Ubicación: ES15.1 - BNCS
ABSTRACT
Ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol belong to a novel generation of antibiotics that correspond with the β-lactam family. It is necessary to having new options in treating infections caused by Gram-negative, non-fermenting multidrug-resistant bacilli due to the significant increase in multidrug resistance in the last decades. Knowing the main characteristics of each drug is key for correct use. (AU)
Asunto(s)
Texto completo
Imprimir
XML
Buscar en Google

Texto completo: 1 Bases de datos: IBECS Asunto principal: Beta-Lactamas / Antibacterianos Límite: Humans Idioma: En Revista: Rev. esp. quimioter Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
Buscar en Google

Texto completo: 1 Bases de datos: IBECS Asunto principal: Beta-Lactamas / Antibacterianos Límite: Humans Idioma: En Revista: Rev. esp. quimioter Año: 2022 Tipo del documento: Article